GREM1 and pancreatic neoplasm: Distinct from a previous study on GREM1 in pancreatic tumors (24, 32), our analysis has reported characteristic immune cell infiltration featuring distinctive immunosuppressive properties in the pancreatic tumor microenvironment, so that the molecule GREM1 acting outside cell may modulate the immune structure and immune efficiency distribution to facilitate tumor progression.